Recently, major interest was aroused by the French discovery of lymphadenopathy associated virus,9 isolated from a case of the homosexual lymphadenopathy syndrome, and by the American recognition in patients with AIDS of retroviruses belonging to the group of human T lymphotropic retroviruses collectively designated HTLV-III.10 Any suggested aetiology must explain the epidemiology and clinical manifestations of AIDS. Why homosexuals, drug users, and haemophiliacs ? What is the link with Haiti ? Why Kaposi's sarcoma? Is this a new disease? Why has it appeared now, and where has it come from?
This report proposes that the infectious agent causing AIDS, whatever its nature, is endemic and unrecognised in parts of sub-Saharan Africa, from where it recently disseminated into external populations. No other explanation unifies the confusing observations on the syndrome. At very least, the common features of AIDS and the pattern of disease in equatorial Africa demand intensive research. Although the possibility that AIDS originated in Africa has been widely mentioned, this hypothesis has not previously been examined in detail.
Is AIDS a new disease?
Previous unrecognised infectious diseases often cause alarm, as witnessed by reactions to legionnaires' disease and the toxic shock syndrome. We have no evidence that any recently described infection is caused by a genuinely new agent.
In rural Africa diagnosis is often inexact. Fever is readily attributed to malaria without confirmation," and pneumonia is often assumed to be pneumococcal or tuberculous. Lack of facilities and the sheer volume of patients generally preclude more than basic investigation.
Infections of all kinds are endemic and the major cause of death. '2 13 In such a situation immunodeficiency would go unrecognised.
Useful analogies can be drawn between the sudden appearance of AIDS and the recent recognition of some African viral haemorrhagic fevers. Only three outbreaks of Marburg virus disease have been documented, the first in laboratory workers in Europe,'4 the second in South Africa,"-and the third in Kenya. ' 
Conclusions
AIDS is almost certainly caused by an infectious agent independent and distinct from hepatitis B virus but transmitted in similar fashion. Although attention is currently focused on a number of lymphotropic retroviruses as the aetiological agent, the origin, epidemiology, and clinical manifestations of the syndrome have not been explained. The concept of a new disease is untenable. The association with Haiti has caused confusion. AIDS in the United States antedated that in Haiti, and the disease was probably introduced into the Haitian population by American homosexuals. It is suggested that the first Americans with AIDS acquired the condition in the early 1970s in Africa. AIDS is being increasingly recognised in black Africans, and the early African cases preceded the first documented American cases by several years.
The hypothesis that AIDS originated in rural equatorial Africa best explains the sudden emergence and clinical features of the syndrome. The clinical spectrum of AIDS, with Kaposi's sarcoma, Burkitt's lymphoma, other lymphomas, enteric infections, and other parasitic diseases, is strikingly reminiscent of the pattern of disease in sub-Saharan Africa. Inadequate attention has been paid to the geographical pathology of the diverse manifestations of this "new" syndrome.
The arguments put forward are my own, but I thank various colleagues for discussion. I am grateful to Ruth Nao for secretarial help. (Accepted 13July 1984) Clinical curio: monoamine oxidase inhibitors and non-alcoholic beer Patients prescribed monoamine oxidase inhibitors are warned not to drink alcohol (product information; Smith, Kline, and French) because ethyl alcohol and monoamine oxidase inhibitors may potentiate one another's action' and because certain alcoholic drinksnotably beers, some liqueurs, and fortified wine-contain substantial quantities of tyramine, which can lead to hypertensive crises in the presence of monoamine oxidase inhibitors.2 Patients are similarly advised not to eat foods with a high tyramine content. A patient who had been advised to drink, if at all, only small quantities of distilled spirits or dry white wine took a proprietary tablet containing tranylcypromine 10 mg plus trifluoperazine 1 mg for several years, varying the dose from one to three tablets daily. Only once did he suffer a "head," which was not typically vascular and related to drinking too much champagne at a wedding. A friend subsequently persuaded him to drink three bottles of a popular non-alcoholic beer, after which he suffered a severe typical vascular headache for the first time ever.
Gas-liquid chromatography showed that a sample of this nonalcoholic beer contained tyramine hydrochloride 10 ug/ml, and N-methyltyramine 10 jig/ml. A can of an English non-alcoholic lager showed lower but still appreciable concentrations of 0 7 ,ug/ml and 0 1 ,ug/ml respectively. The identities of these gas chromatographic peaks was confirmed mass spectrometrically. Normal beers may contain up to 10 ,ig/ml of tyramine. Consumption of the newly introduced non-alcoholic beers and lagers is likely to increase. Doctors should be aware of their possible interaction with monoamine oxidase inhibitors. Patients receiving such drugs should be advised to abstain totally from certain specific types of alcoholic and non-alcoholic drink, especially beers, rather than from alcohol generally.-R DRAPER, assistant medical director, Dublin, M SANDLER, professor of chemical pathology, London, P L WALKER, biochemist, London. 
